Earnings (Loss) Per Common Share (Tables)

3 Months Ended

Mar. 31, 2021

Computation of basic and diluted earnings per share

The following table sets forth the computation of basic and diluted earnings per share available for common stockholders (in thousands, except per share data):


	For the Three Months Ended March 31,
	2021		2020
Loss from continuing operations	$	(11,190)	$	(78,487)
Gain (loss) from discontinued operations, net of tax	1,383		(265)
Net loss	(9,807)		(78,752)
Less:
Net loss attributable to non-controlling interests	—		—
Net loss available for common shareholders - basic and diluted	$	(9,807)	$	(78,752)

Weighted-average common shares outstanding - basic and diluted	84,670		84,793

Loss per common share
Basic and diluted
Continuing operations	$	(0.13)	$	(0.93)
Discontinued operations	0.01		—
Basic and diluted loss per share attributable to common shareholders of Evolent Health, Inc.	$	(0.12)	$	(0.93)

Schedule of antidilutive securities excluded from computation of earnings per share

Anti-dilutive shares (in thousands) excluded from the calculation of weighted-average common shares presented above are presented below:


	For the Three Months Ended March 31,
	2021	2020
Restricted stock units ("RSUs"), performance-based RSUs and leveraged stock units ("LSUs")	1,531	199
Stock options	1,865	972
Convertible senior notes	12,696	10,361
Total	16,092	11,532